| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $920.0M | +38.9% |
| Cost of Revenue | $518.2M | +37.8% |
| Gross Profit | $401.8M | +40.3% |
| R&D Expense | $78.4M | +19.8% |
| SG&A Expense | $57.5M | +24.6% |
| Operating Income | $212.4M | +66.8% |
| Interest Expense | $5.6M | +15.3% |
| Pre-tax Income | $204.9M | +70.1% |
| Income Tax | $21.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $185.6M | -37.1% |
| Short-term Investments | $246.6M | — |
| Accounts Receivable | $169.8M | +62.6% |
| Inventory | $242.4M | +24.3% |
| Current Assets | $877.6M | +41.7% |
| Total Assets | $1.01B | +34.6% |
| Current Liabilities | $248.1M | +65.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $215.6M | +43.6% |
| Capital Expenditures | $10.7M | +22.5% |
| Investing Cash Flow | -$257.3M | -2850.8% |
| Financing Cash Flow | -$65.5M | -24.8% |
| Free Cash Flow | $204.9M | +44.9% |
| +0.1% |
| Net Income | $183.1M | +85.6% |
| EPS (Basic) | $5.54 | +88.4% |
| EPS (Diluted) | $5.46 | +89.6% |
| Total Liabilities |
| $346.4M |
| +61.6% |
| Stockholders' Equity | $667.3M | +23.8% |